tiprankstipranks
Trending News
More News >
Emergent Biosolutions (EBS)
NYSE:EBS
US Market

Emergent Biosolutions (EBS) Income Statement

Compare
1,358 Followers

Emergent Biosolutions Income Statement

Last quarter (Q4 2025), Emergent Biosolutions's total revenue was $148.70M, a decrease of -23.63% from the same quarter last year. In Q4, Emergent Biosolutions's net income was $-54.60M. See Emergent Biosolutions’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 742.90M$ 1.04B$ 1.05B$ 1.12B$ 1.77B
Gross Profit
$ 350.60M$ 375.40M$ 360.00M$ 473.00M$ 793.20M
Operating Expenses
$ 240.40M$ 484.10M$ 1.09B$ 643.00M$ 451.80M
Depreciation and Amortization
$ 98.30M$ 105.60M$ 121.10M$ 125.00M$ 118.20M
EBITDA
$ 208.50M$ 53.40M$ -47.00M$ 15.70M$ 504.20M
Operating Income
$ 110.20M$ -108.70M$ -726.40M$ -170.00M$ 341.40M
Other Income/Expenses
$ -27.40M$ -34.20M$ -4.80M$ -49.00M$ -38.20M
Pretax Income
$ 82.80M$ -142.90M$ -731.20M$ -219.00M$ 303.20M
Net Income
$ 52.60M$ -190.60M$ -760.50M$ -211.60M$ 219.50M
Per Share Metrics
Basic EPS
$ 0.98$ -3.60$ -14.85$ -4.47$ 4.10
Diluted EPS
$ 0.93$ -3.60$ -14.85$ -4.47$ 4.06
Weighted Average Shares Outstanding
53.50M 53.00M 51.20M 50.10M 53.50M
Weighted Average Shares Outstanding (Diluted)
56.70M 53.00M 51.20M 50.10M 54.10M
Currency in USD

Emergent Biosolutions Earnings and Revenue History